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suggesting pericarditis. Patient presented with ST segment eleva-
tions without reciprocal depression and PR-segment depressions 
on a 12-lead electrocardiography (ECG) (Fig. 1a) with increased 
cardiac enzyme levels (cardiac troponin level at admission time 
was 1.936 ng/mL and two days later peak troponin level was 8.559 
ng/mL). The patient smoked 1–2 cigarettes per day for 10 years, 
but denied illicit drug or alcohol abuse. He had no atheroscle-
rotic coronary artery disease risk factors (family history, hyper-
lipidemia, etc.) apart from active smoking. Physical examination 
showed no abnormal findings. He had a history of viral upper 
respiratory tract infection 1 week ago. Given the age of the pa-
tient and characteristics of the chest pain (sitting up and leaning 
forward tends to ease the pain, while lying down and breathing 
deep worsens it), acute myopericarditis was initially assumed. At 
the time of admission, transthoracic echocardiography revealed 
that left ventricular ejection fraction (LVEF) was 60% and no ab-
normality was found in segmental wall motion. Left ventricular 
diameter in diastole measured in the normal range (4.8 cm). Mini-
mal circumferential pericardial effusion was present. However, 
urgent diagnostic coronary angiography was performed due to 
persistent, severe chest pain, current risk factor (active smok-
ing) and high cardiac troponin levels. Coronary angiography indi-
cated a noncritical plaque in the left anterior descending (LAD) 
coronary artery (Fig. 1-b1 and 1-b2-white arrowhead). Right and 
Left circumflex coronary arteries were normal (Fig. 1-b2, 1-b3). 
A diagnosis of acute myopericarditis was made and the patient 
was treated with colchicine, ibuprofen, and proton-pump inhibi-
tor (omeprazole) throughout hospitalization. On the fourth hospi-
tal day, the patient's symptoms largely subsided. During the hos-
pitalization period, troponin levels decreased progressively and 
the patient was discharged asymptomatic with prescriptions for 
colchicine, ibuprofen, and omeprazole for continued usage.
Ten days after discharge, the patient was admitted to the 
emergency department again with chest pain at rest spreading 
to the left arm while he was still taking the prescribed medica-
tion. The patient's chest pain was an ischemic type, contrasting 
with his previous pain on the previous visit, accompanied by cold 
sweating. The ECG on admission indicated acute anterior wall 
myocardial infarction (MI) (Fig. 2a). The patient was immediately 
taken to the catheter laboratory and a second coronary angiogra-
phy revealed 100% thrombotic occlusion in the LAD-proximal re-
gion. After thrombus aspiration, 2 consecutive drug-eluting stents 
were implanted due to severe thrombotic residues and dissec-
tion. Complete opening and distal TIMI-3 flow were achieved 
after the procedure (Fig. 2-b1 - 2-b3). At second admission, the 
echocardiogram revealed segmental (septum, mid-anterior, api-
cal) wall motion dysfunction of left ventricular origin with a de-
creased LVEF, 45%). Treatments consisted of double antiplatelets 
(aspirin and ticagrelor), ACE inhibitor (perindopril), beta-blocker 
(metoprolol) and lipid-modulating (atorvastatin) drugs. Four days 
later he was discharged without any complications.
Two and a half months after discharge, the patient was ad-
mitted to the emergency department again with constricting 
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Introduction
Patients aged less than 40 years old only account for 1.2% of 
all patients with acute myocardial infarction (AMI) (1). Several 
studies as well as meta-analyses have revealed that the use of 
non-steroidal anti-inflammatory drugs (NSAIDs) can be associ-
ated with an increased relative risk of AMI in patients with or 
without heart disease or other risk factors for coronary artery 
disease (2-7). Diclofenac and ibuprofen, the most frequently 
used NSAIDs, are associated with a 40%–50% increased rela-
tive risk of AMI, even for low cumulative NSAID amounts (8). The 
AMI risk in patients with and without cardiovascular risk fac-
tors showed a similar elevation (8). The present paper reports 
an exceedingly rare presentation of AMI in a very young male 
associated with acute myopericarditis treatment.
Case Report
A 21-year-old man with no prior medical history presented to 
the emergency department with a 10 hour history of chest pain 
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retrosternal chest pain radiating to the left arm, which started 
suddenly while at rest. Admission ECG revealed ST segment ele-
vations in the anterior leads. The patient was questioned and he 
revealed that he had not taken the dual antiplatelet or other pre-
scribed drugs for one month. The patient underwent emergency 
coronary angiography again and both stents in the LAD coronary 
artery were 100% thrombotic occluded (Fig. 3a). Multiple balloon 
dilations were applied to the occluded stents, distal TIMI 2 flow 
was provided (Fig. 3b, 3c), and the procedure was terminated 
with intracoronary abciximab administration. Dual antiplatelet 
drugs (aspirin and ticagrelor) and other medications (perindo-
pril, metoprolol, atorvastatin) were started again and the patient 
was discharged 48 hours later with the same treatment previ-
ously administered on the second emergency department visit. 
It was recommended that he use the dual antiplatelet therapy for 
at least 1 year and the other drugs for life-long.
Discussion
The literature indicates that all NSAIDs are associated 
with a dose-related increased risk of AMI (2-5). Diclofenac and 
ibuprofen, the most frequently used NSAIDs, were associated 
with a 40%–50% increased relative risk of AMI, even for low 
cumulative NSAID amounts (6-8). The AMI risk in patients with 
and without cardiovascular risk factors was similarly elevated 
(8). Celecoxib-associated MI risk seems to depend on continu-
ous usage of the drug for more than 30 days, whereas ibupro-
fen, rofecoxib, diclofenac, and naproxen, a heightened MI risk 
occurs within 7 days of use (8). The relative risk for individual 
NSAID use varies by age with higher relative AMI risks ob-
served in younger people (<60 years of age) (8). The underlying 
pathophysiological mechanism(s) of the relationship between 
NSAID use and increased cardiovascular risk is still specula-
tive. NSAIDs inhibit both COX-1 and COX-2 enzymes and sub-
sequently inhibit, competitively, and irreversibly, the synthesis 
of prostacyclin. The inhibition of COX-2-dependent prostacyclin 
leads to a reduction of inflammation and pain but might also in-
crease the risk of coronary thrombosis (9). In our patient other 
possible causes for AMI were ruled out. It is tempting to specu-
late that in our case, combined NSAID/COX-2 inhibitor therapy 
may have concomitantly triggered platelet hyperreactivity and 
imbalance between thromboxane/prostacyclin, resulting in a 
Figure 1. Electrocardiogram at admission (a) and coronary angiography (b). (b1) Left anterior descending artery (LAD) and Left circumflex (LCx) artery 
in spider projection; (b2) LAD artery in anteroposterior projection with cranial angulation. The white arrowheads indicate the plaque at the LAD; (b3) 
Right coronary artery (RCA)
a
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prothrombotic endothelium. Thus, we suggest that the use of 
ibuprofen might have triggered a coronary artery spasm/vul-
nerable plaque rupture and subsequent thrombosis, and finally 
acute anterior ST-elevation myocardial infarction. A critique 
of our previous treatment, as the AMI is due to drug-induced 
plaque rupture/erosion of a fixed stenosis as shown by the 
first angiogram, thrombus aspiration followed by a GpIIb/IIIa 
inhibitor infusion for 24–48 hours would have been sufficient to 
Figure 2. Electrocardiogram at second admission (a) and Coronary angiography and percutaneous coronary intervention (b). (b1) The spider view 
shows acute thrombotic occlusion of the left anterior descending (LAD) artery (b2) Anteroposterior cranial projection showing LAD lesion after 
thrombus aspiration; (b3) Implantation of stent in the proximal LAD artery
a
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Figure 3. Coronary angiography and percutaneous coronary intervention. Left anterior descending coronary (LAD) artery stents were 100% thrombotic 
occluded (a). Multiple balloon dilations were applied to the occluded stents and the vessel was opened (b, c)
a b c
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completely resolve the residual thrombus thereby eliminating 
the unnecessary (long) stenting and avoiding the risk of subse-
quent stent thrombosis.
Conclusion
During the treatment of myopericarditis, the use of NSAIDs, 
such as ibuprofen, may be a trigger of cardiac thrombotic events 
in younger atherosclerotic patients.
Informed consent: 'Informed consent was obtained from the patient.
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